Jamieson Wellness Inc. (TSE:JWEL - Get Free Report) Senior Officer Paul Michael Galbraith sold 1,044 shares of the company's stock in a transaction on Monday, May 26th. The shares were sold at an average price of C$35.06, for a total transaction of C$36,603.06.
Jamieson Wellness Price Performance
Shares of Jamieson Wellness stock traded up C$0.26 during trading hours on Friday, reaching C$35.71. The stock had a trading volume of 107,535 shares, compared to its average volume of 75,780. The stock's 50 day moving average is C$32.12 and its 200 day moving average is C$33.25. The firm has a market capitalization of C$1.50 billion, a PE ratio of 37.52 and a beta of 0.63. Jamieson Wellness Inc. has a twelve month low of C$26.00 and a twelve month high of C$38.20. The company has a current ratio of 2.76, a quick ratio of 1.08 and a debt-to-equity ratio of 75.70.
Jamieson Wellness Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Friday, March 14th were given a $0.21 dividend. The ex-dividend date was Friday, March 7th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 2.35%. Jamieson Wellness's dividend payout ratio (DPR) is currently 88.26%.
Analyst Ratings Changes
Separately, Royal Bank of Canada upped their price objective on shares of Jamieson Wellness from C$40.00 to C$42.00 in a research report on Friday, May 9th.
Get Our Latest Analysis on JWEL
Jamieson Wellness Company Profile
(
Get Free Report)
Jamieson Wellness Inc is engaged in the manufacturing, distributing, and marketing of branded natural health products, including vitamins, minerals, and supplements. The company operates in two segments: The Jamieson brands and The Strategic Partners. The majority of its revenue comes from the Jamieson brand segment.
Read More
Before you consider Jamieson Wellness, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jamieson Wellness wasn't on the list.
While Jamieson Wellness currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
